Angelina Bisconte is an authority in utilizing human primary biological tissue and cells in research and drug discovery. She is a developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer, and is an expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells, Dendritic cells (pDCc/mDCs), and MDSCs. She serves as a strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Additionally, Angelina maintains a broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. She is a scientific leader for Precision’s Biomaterials commercial sourcing.
Choosing the Optimal Sample Type for Flow Cytometry: Key Considerations and Case Studies
|
has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778846, hs_child_table_id=0, hs_updated_at=1713168962876, hs_published_at=1744844126301, description=Angelina Bisconte is an authority in utilizing human primary biological tissue and cells in research and drug discovery. She is a developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer, and is an expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells, Dendritic cells (pDCc/mDCs), and MDSCs. She serves as a strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Additionally, Angelina maintains a broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. She is a scientific leader for Precision’s Biomaterials commercial sourcing., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Angelina%20Bisconte.webp',altText='Angelina Bisconte',fileId=164430032419}, linkedin=https://www.linkedin.com/in/angelinabisconte, hs_name=, hs_path=, lastname=Bisconte, hs_initial_published_at=1716136551646, hs_created_at=1709645745077, hs_is_edited=false, hs_deleted_at=0, name=Angelina, job=, slug=angelina-bisconte, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
Moving from Exploratory to Clinical Flow Cytometry Assays: 3 Critical Considerations
|
has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778846, hs_child_table_id=0, hs_updated_at=1713168962876, hs_published_at=1744844126301, description=Angelina Bisconte is an authority in utilizing human primary biological tissue and cells in research and drug discovery. She is a developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer, and is an expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells, Dendritic cells (pDCc/mDCs), and MDSCs. She serves as a strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Additionally, Angelina maintains a broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. She is a scientific leader for Precision’s Biomaterials commercial sourcing., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Angelina%20Bisconte.webp',altText='Angelina Bisconte',fileId=164430032419}, linkedin=https://www.linkedin.com/in/angelinabisconte, hs_name=, hs_path=, lastname=Bisconte, hs_initial_published_at=1716136551646, hs_created_at=1709645745077, hs_is_edited=false, hs_deleted_at=0, name=Angelina, job=, slug=angelina-bisconte, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
Taking a Holistic Approach to Sample Management and Sample Processing for Your Clinical Trial
|
has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778846, hs_child_table_id=0, hs_updated_at=1713168962876, hs_published_at=1744844126301, description=Angelina Bisconte is an authority in utilizing human primary biological tissue and cells in research and drug discovery. She is a developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer, and is an expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells, Dendritic cells (pDCc/mDCs), and MDSCs. She serves as a strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Additionally, Angelina maintains a broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. She is a scientific leader for Precision’s Biomaterials commercial sourcing., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Angelina%20Bisconte.webp',altText='Angelina Bisconte',fileId=164430032419}, linkedin=https://www.linkedin.com/in/angelinabisconte, hs_name=, hs_path=, lastname=Bisconte, hs_initial_published_at=1716136551646, hs_created_at=1709645745077, hs_is_edited=false, hs_deleted_at=0, name=Angelina, job=, slug=angelina-bisconte, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
